Nasdaq Biotechnology Ishares ETF (IBB)

This company is riding a powerful trend in the future of healthcare. Plus, it offers high growth, a huge potential market and a path to profitability.

The 5 Best Tech ETFs to Buy for Safer Growth

By Tezcan Gecgil, InvestorPlace Contributor Aug 25, 2020

Here are five tech ETFs to buy if you believe that global technology stocks will continue to enjoy their solid runs in the coming quarters.

3 Biotech Stock ETFs to Buy For Further Upside In 2021

By Nicolas Chahine, InvestorPlace Contributor Aug 17, 2020

Biotech stocks are winners this year, but there's still room to buy in for profit taking. ETFs such as IBB, XBI and XLV will continue to win.

Biotech Stocks Have Been on Fire, But Timing Is Everything

By Nicolas Chahine, InvestorPlace Contributor May 27, 2020

Consensus is that the experts will find a vaccine to Covid-19 soon, so the biotech stocks have rallied hard. Buying them now carries risk.

Biotech Stocks: Coronavirus Response Shows How Far We’ve Come …

By Matt McCall, Editor, MoneyWire Mar 9, 2020

Look for biotech stocks as a group to gain more than 20% this year … with the best, most innovative firms more than doubling.

3 Healthcare Stocks to Buy This Year

By Nicolas Chahine, InvestorPlace Contributor Feb 24, 2020

The buyers are in charge of the healthcare stocks this year. And judging from their charts, these stocks and ETFs in particular offer great opportunities.

First-Mover Advantage Will Benefit Amarin Stock More Than You Think

By Ian Cooper Feb 24, 2020

There’s no reason Amarin stock won’t become a big success with Vascepa, especially with access to millions of patients.

The Top Performing Sector in 2020 Will Be …

By Matt McCall, Editor, MoneyWire Feb 19, 2020

The future of healthcare will really start to take shape this year, and the next decade will bring advancements that we can only imagine in our wildest dreams.

3 Top Drug Stocks to Own In 2020

By Ian Cooper Jan 3, 2020

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

3 of the Best Biotech ETFs on the Market

By Todd Shriber, InvestorPlace Contributor Jan 2, 2020

The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.

The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida

From Benzinga Feb 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 25) Apyx Medical Corp (NASDAQ:...

The Importance of the 50-Day Moving Average

From Talk Markets Feb 25, 2021

Looking forward, ideally, QQQs should hold the 50-DMA at 320, although we would have a stop under Tuesday’s low or under 311 to give it some room.

The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO

From Benzinga Feb 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 23) AxoGen, Inc (NASDAQ:...

Nasdaq Biotechnology Ishares ETF (IBB)

IBB Stock Predictions, Articles, and Nasdaq Biotechnology Ishares ETF News

Subscriber Sign in